Skip to main content

Apremilast Side Effects

Medically reviewed by Philip Thornton, DipPharm. Last updated on Sep 27, 2023.

Applies to apremilast: oral tablet.

Serious side effects of Apremilast

Along with its needed effects, apremilast may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking apremilast:

Rare

Incidence not known

Other side effects of Apremilast

Some side effects of apremilast may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to apremilast: oral tablet.

General

The most common adverse reactions reported in patients (across all treatment indications) included diarrhea, nausea, upper respiratory tract infections, headache, tension headache, upper abdominal pain, vomiting, and back pain.[Ref]

Dermatologic

Common (1% to 10%): Folliculitis

Uncommon (0.1% to 1%): Urticaria, rash, psoriasis

Frequency not reported: Angioedema

Gastrointestinal

Very common (10% or more): Diarrhea (up to 41.3%), nausea (up to 19.2%)

Common (1% to 10%): Abdominal discomfort, upper abdominal pain, vomiting, abdominal pain, dyspepsia, frequent bowel movements, tooth abscess, gastroenteritis, gastroesophageal reflux disease

Gastrointestinal adverse reactions generally occurred within the first 2 weeks of treatment and usually resolved within 4 weeks.

Hypersensitivity

Uncommon (0.1% to 1%): Hypersensitivity

Postmarketing reports: Hypersensitivity reactions (including angioedema, anaphylaxis)

Metabolic

Common (1% to 10%): Decreased appetite

Musculoskeletal

Common (1% to 10%): Back pain, arthralgia

Nervous system

Very common (10% or more): Headache (up to 14.4%)

Common (1% to 10%): Tension headache, sinus headache, migraine

Other

Very common (10% or more): Decreased weight (up to 14.3%)

Common (1% to 10%): Fatigue

Psychiatric

Common (1% to 10%): Insomnia, depression, depressed mood

Uncommon (0.1% to 1%): Suicidal ideation/behavior

Postmarketing reports: Completed suicide

Renal

Common (1% to 10%): Urinary tract infection

Respiratory

Very common (10% or more): Upper respiratory tract infections (up to 11.5%)

Common (1% to 10%): Bronchitis, viral upper respiratory tract infections, nasopharyngitis, cough

Frequently asked questions

References

1. Product Information. Otezla (apremilast). Amgen USA. 2023;SUPPL-12.

2. Product Information. Otezla (apremilast). Celgene Pty Ltd. 2023.

3. Product Information. Otezla (apremilast). Amgen Ltd. 2021.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.